Penn spinout Linnaeus Therapeutics gets key FDA designation
March 11, 2021 at 18:50 PM EST
The company is developing new cancer therapies based on the discoveries of a Penn researcher.
|
||||||||||||
|
||||||||||||
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Home | News | Travel | Restaurants | Nightlife | Things To Do | Shopping | Calendar | Directory | Real Estate | Blog | More
|